WHO ICTRP trial
Phase II Trial of capsaicin gel application for prevent paclitaxel-induced…
TCTR20150626002 · Thai Clinical Trials Registry (TCTR) · Recruiting
Key facts
| Trial ID | TCTR20150626002 |
|---|---|
| Public title | Phase II Trial of capsaicin gel application for prevent paclitaxel-induced peripheral neuropathy |
| Scientific title | Phase II Trial of capsaicin gel application for prevent paclitaxel-induced peripheral neuropathy |
| Primary sponsor | Khumklao Foundation Under The Royal Patronage, Bhumibol Aduladej Hospital |
| Secondary sponsors | Bangkok Drug Co. Ltd. |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | Thailand |
| Conditions | Breast cancer Non small cell lung cancer Paclitaxel Breast neoplasms Non-small-cell lung carcinoma Paclitaxel Peripheral Nervous System Diseases;Breast neoplasms Non-small-cell lung carcinoma Paclitaxel Peripheral Nervous System Diseases |
| Interventions | 0.025% w/w Capsaicin gel;Experimental Drug;Capsaicin gel |
| Registration date | Jun 26, 2015 |
| Target size | 32 |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: